Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab on Vascular Inflammation in Psoriasis
NCT00940862Phase 4Completed
- Sponsor
- Innovaderm Research
- Start
- Jul 2009
- Primary completion
- Jun 2011
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of adalimumab in plaque psoriasis, sponsored by Innovaderm Research. Started Jul 2009; status: completed.
02
Drugs
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT00940862.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00940862.